Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Barclays PLC Major Shareholding Notification 2021

Feb 17, 2021

5250_rns_2021-02-17_9491886c-dff1-42fd-a736-77e3f1557491.html

Major Shareholding Notification

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

FORM 8.3 - WILLIS TOWERS WATSON PLC

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 16 February 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
2,105,212 1.63% 489,888 0.38%
(2) Derivatives (other than options):
183,127 0.14% 318,405 0.25%
(3) Options and agreements to
purchase/sell: 6,000 0.00% 6,000 0.00%
(4) TOTAL:
2,294,339 1.78% 814,293 0.63%

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale Number of relevant securities Price per unit
Purchase 1 229.1200 USD
Purchase 3 228.2900 USD
Purchase 8 227.8400 USD
Purchase 8 228.5300 USD
Purchase 10 228.1520 USD
Purchase 21 227.6957 USD
Purchase 24 228.4491 USD
Purchase 50 227.3800 USD
Purchase 100 227.8500 USD
Purchase 100 229.3050 USD
Purchase 100 227.4600 USD
Purchase 158 227.1768 USD
Purchase 217 228.1501 USD
Purchase 237 228.2919 USD
Purchase 537 227.7170 USD
Purchase 719 228.4155 USD
Purchase 997 227.9844 USD
Purchase 3,236 228.2763 USD
Purchase 5,000 228.5156 USD
Purchase 7,375 228.0141 USD
Purchase 8,808 228.2875 USD
Purchase 131,373 228.1100 USD
Sale 1 227.7200 USD
Sale 4 228.4550 USD
Sale 6 228.5200 USD
Sale 10 228.1520 USD
Sale 10 228.0220 USD
Sale 12 228.1600 USD
Sale 12 228.3850 USD
Sale 12 228.3300 USD
Sale 13 228.1373 USD
Sale 16 228.5700 USD
Sale 18 228.2533 USD
Sale 18 227.9400 USD
Sale 18 228.1283 USD
Sale 22 228.6000 USD
Sale 39 228.1423 USD
Sale 48 228.0487 USD
Sale 69 228.0000 USD
Sale 100 227.8500 USD
Sale 100 227.4600 USD
Sale 100 228.6400 USD
Sale 100 228.7000 USD
Sale 100 228.4500 USD
Sale 106 228.3328 USD
Sale 120 228.3566 USD
Sale 138 228.5300 USD
Sale 237 228.2919 USD
Sale 343 228.4773 USD
Sale 384 228.4536 USD
Sale 418 228.5312 USD
Sale 513 227.6593 USD
Sale 583 228.5156 USD
Sale 883 228.0133 USD
Sale 1,029 227.9861 USD
Sale 1,438 228.4244 USD
Sale 2,234 228.5693 USD
Sale 5,143 228.3650 USD
Sale 6,658 227.9941 USD
Sale 6,695 228.2194 USD
Sale 131,337 228.1100 USD

(b) Derivatives transactions (other than options transactions)

Product Name Nature of transaction Number of relevant securities Price per
unit
SWAP Long 1 373,634,890.0000 USD
SWAP Long 1 159,717,120.0000 USD

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option
Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)

(ii) Exercising

Product name,

e.g. call option
Number of securities Exercise price per unit (Note 5)

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)
Details Price per unit

(if applicable) (Note 5)

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 17 Feb 2021
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates
Call Options Purchased 6,000 220.0000 American Jul 16, 2021
Put Options Purchased -6,000 200.0000 American Jul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210217005623/en/

BARCLAYS PLC